USD 8.28
(-5.75%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 606.06 Million USD | 0.3% |
2022 | 604.27 Million USD | -0.08% |
2021 | 604.77 Million USD | 187.42% |
2020 | 210.41 Million USD | 76.73% |
2019 | 119.06 Million USD | 21.33% |
2018 | 98.13 Million USD | 1.76% |
2017 | 96.43 Million USD | 27.5% |
2016 | 75.63 Million USD | 31.83% |
2015 | 57.37 Million USD | 991.42% |
2014 | 5.25 Million USD | 59.59% |
2013 | 3.29 Million USD | 6.36% |
2012 | 3.09 Million USD | 18.75% |
2011 | 2.6 Million USD | 93.47% |
2010 | 1.34 Million USD | -11.65% |
2009 | 1.52 Million USD | 8.73% |
2008 | 1.4 Million USD | 67.64% |
2007 | 837.08 Thousand USD | 86.45% |
2006 | 448.94 Thousand USD | 0.0% |
2005 | - USD | 0.0% |
2004 | - USD | -100.0% |
2003 | 590 Thousand USD | 0.0% |
2002 | - USD | 0.0% |
2001 | - USD | 0.0% |
2000 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 538.92 Million USD | 0.13% |
2024 Q3 | 602.55 Million USD | 0.11% |
2024 Q2 | 339.57 Million USD | -36.99% |
2023 FY | 606.06 Million USD | 0.3% |
2023 Q2 | 602.22 Million USD | -0.19% |
2023 Q3 | 599.48 Million USD | -0.46% |
2023 Q1 | 603.35 Million USD | -0.15% |
2023 Q4 | 606.06 Million USD | 1.1% |
2022 Q1 | 606.62 Million USD | 0.31% |
2022 Q2 | 605.78 Million USD | -0.14% |
2022 Q3 | 605.08 Million USD | -0.12% |
2022 Q4 | 604.27 Million USD | -0.13% |
2022 FY | 604.27 Million USD | -0.08% |
2021 Q1 | 576.81 Million USD | 174.13% |
2021 Q2 | 580.7 Million USD | 0.67% |
2021 Q3 | 604.26 Million USD | 4.06% |
2021 Q4 | 604.77 Million USD | 0.08% |
2021 FY | 604.77 Million USD | 187.42% |
2020 Q4 | 210.41 Million USD | -0.26% |
2020 Q3 | 210.96 Million USD | -0.01% |
2020 Q1 | 138.94 Million USD | 16.7% |
2020 FY | 210.41 Million USD | 76.73% |
2020 Q2 | 210.97 Million USD | 51.85% |
2019 Q2 | 123.21 Million USD | 9.14% |
2019 Q1 | 112.89 Million USD | 15.05% |
2019 Q3 | 120.87 Million USD | -1.89% |
2019 Q4 | 119.06 Million USD | -1.5% |
2019 FY | 119.06 Million USD | 21.33% |
2018 Q3 | 96.42 Million USD | -23.55% |
2018 FY | 98.13 Million USD | 1.76% |
2018 Q2 | 126.12 Million USD | 38.85% |
2018 Q1 | 90.83 Million USD | -5.8% |
2018 Q4 | 98.13 Million USD | 1.77% |
2017 Q3 | 96.57 Million USD | -4.06% |
2017 Q4 | 96.43 Million USD | -0.14% |
2017 FY | 96.43 Million USD | 27.5% |
2017 Q1 | 102.15 Million USD | 35.06% |
2017 Q2 | 100.66 Million USD | -1.46% |
2016 Q1 | 56.44 Million USD | -1.63% |
2016 FY | 75.63 Million USD | 31.83% |
2016 Q4 | 75.63 Million USD | 31.07% |
2016 Q3 | 57.7 Million USD | 1.26% |
2016 Q2 | 56.98 Million USD | 0.97% |
2015 Q3 | 5.74 Million USD | -6.66% |
2015 Q4 | 57.37 Million USD | 899.06% |
2015 Q2 | 6.15 Million USD | -2.75% |
2015 Q1 | 6.32 Million USD | 20.35% |
2015 FY | 57.37 Million USD | 991.42% |
2014 Q3 | 5.21 Million USD | 11.13% |
2014 Q2 | 4.69 Million USD | 17.01% |
2014 Q4 | 5.25 Million USD | 0.84% |
2014 FY | 5.25 Million USD | 59.59% |
2014 Q1 | 4 Million USD | 21.71% |
2013 FY | 3.29 Million USD | 6.36% |
2013 Q4 | 3.29 Million USD | 23.97% |
2013 Q3 | 2.65 Million USD | -10.33% |
2013 Q2 | 2.96 Million USD | 4.44% |
2013 Q1 | 2.83 Million USD | -8.4% |
2012 FY | 3.09 Million USD | 18.75% |
2012 Q1 | 3.02 Million USD | 15.84% |
2012 Q4 | 3.09 Million USD | -9.18% |
2012 Q2 | 3.18 Million USD | 5.46% |
2012 Q3 | 3.41 Million USD | 7.03% |
2011 FY | 2.6 Million USD | 93.47% |
2011 Q4 | 2.6 Million USD | 64.44% |
2011 Q3 | 1.58 Million USD | 26.17% |
2011 Q2 | 1.25 Million USD | 3.46% |
2011 Q1 | 1.21 Million USD | -9.87% |
2010 Q3 | 1.38 Million USD | -3.27% |
2010 FY | 1.34 Million USD | -11.65% |
2010 Q1 | 1.63 Million USD | 6.9% |
2010 Q4 | 1.34 Million USD | -2.95% |
2010 Q2 | 1.43 Million USD | -11.96% |
2009 Q1 | 1.37 Million USD | -2.28% |
2009 FY | 1.52 Million USD | 8.73% |
2009 Q2 | 1.53 Million USD | 11.64% |
2009 Q3 | 1.56 Million USD | 2.31% |
2009 Q4 | 1.52 Million USD | -2.59% |
2008 Q4 | 1.4 Million USD | 33.1% |
2008 Q2 | 854.29 Thousand USD | -4.06% |
2008 Q1 | 890.46 Thousand USD | 6.38% |
2008 FY | 1.4 Million USD | 67.64% |
2008 Q3 | 1.05 Million USD | 23.41% |
2007 Q2 | 599.11 Thousand USD | -1.79% |
2007 Q1 | 610.05 Thousand USD | 35.89% |
2007 Q4 | 837.08 Thousand USD | 17.44% |
2007 FY | 837.08 Thousand USD | 86.45% |
2007 Q3 | 712.75 Thousand USD | 18.97% |
2006 Q1 | 1.53 Million USD | 0.0% |
2006 Q3 | 1.94 Million USD | 18.54% |
2006 Q2 | 1.63 Million USD | 7.07% |
2006 Q4 | 448.94 Thousand USD | -76.9% |
2006 FY | 448.94 Thousand USD | 0.0% |
2005 Q3 | 1.26 Million USD | 0.0% |
2005 FY | - USD | 0.0% |
2005 Q1 | - USD | 0.0% |
2005 Q2 | - USD | 0.0% |
2005 Q4 | - USD | -100.0% |
2004 Q3 | - USD | 0.0% |
2004 FY | - USD | -100.0% |
2004 Q2 | - USD | -100.0% |
2004 Q4 | - USD | 0.0% |
2004 Q1 | 715 Thousand USD | 21.19% |
2003 Q4 | 590 Thousand USD | 0.0% |
2003 Q1 | 58.66 Thousand USD | 0.0% |
2003 FY | 590 Thousand USD | 0.0% |
2003 Q2 | - USD | -100.0% |
2003 Q3 | - USD | 0.0% |
2002 Q3 | - USD | 0.0% |
2002 Q2 | - USD | 0.0% |
2002 FY | - USD | 0.0% |
2002 Q1 | - USD | 0.0% |
2002 Q4 | - USD | 0.0% |
2001 FY | - USD | 0.0% |
2001 Q4 | - USD | 0.0% |
2001 Q3 | - USD | 0.0% |
2001 Q1 | - USD | 0.0% |
2001 Q2 | - USD | 0.0% |
2000 Q3 | 17.05 Thousand USD | 0.0% |
2000 Q1 | 20.05 Thousand USD | 0.0% |
2000 FY | - USD | 0.0% |
2000 Q4 | - USD | -100.0% |
2000 Q2 | 17.05 Thousand USD | -14.96% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
bioAffinity Technologies, Inc. | 1.11 Million USD | -54087.424% |
Aspira Women's Health Inc. | 1.43 Million USD | -42282.448% |
Castle Biosciences, Inc. | 14.19 Million USD | -4168.693% |
Exact Sciences Corporation | 2.47 Billion USD | 75.516% |
IDEXX Laboratories, Inc. | 622.88 Million USD | 2.699% |
Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -745152.324% |
iSpecimen Inc. | 29.13 Thousand USD | -2080466.426% |
Standard BioTools Inc. | 3.98 Million USD | -15116.395% |
Inotiv, Inc. | 399.4 Million USD | -51.741% |
Psychemedics Corporation | 945 Thousand USD | -64034.286% |
Prenetics Global Limited | 867.21 Thousand USD | -69786.822% |
RadNet, Inc. | 812.06 Million USD | 25.367% |
Star Equity Holdings, Inc. | 1.14 Million USD | -52831.79% |
Neuronetics, Inc. | 59.28 Million USD | -922.332% |
OpGen, Inc. | 2.02 Million USD | -29879.432% |
Exagen Inc. | 19.23 Million USD | -3051.521% |
Bionano Genomics, Inc. | 7.17 Million USD | -8346.955% |
CareDx, Inc | 28.27 Million USD | -2043.253% |
Check-Cap Ltd. | - USD | -Infinity% |
Twist Bioscience Corporation | 79.17 Million USD | -665.5% |
Guardant Health, Inc. | 1.13 Billion USD | 46.834% |
Biodesix, Inc. | 35.22 Million USD | -1620.565% |
BioNexus Gene Lab Corp. | 98.76 Thousand USD | -613559.974% |
Precipio, Inc. | 106 Thousand USD | -571663.208% |
Natera, Inc. | 282.94 Million USD | -114.2% |
Fulgent Genetics, Inc. | 10.11 Million USD | -5894.155% |
Sera Prognostics, Inc. | 840 Thousand USD | -72051.071% |
23andMe Holding Co. | 67.84 Million USD | -793.314% |
OPKO Health, Inc. | 222.03 Million USD | -172.962% |
Personalis, Inc. | 1.23 Million USD | -49014.182% |
Aclaris Therapeutics, Inc. | 3.07 Million USD | -19615.973% |
Applied DNA Sciences, Inc. | 739.16 Thousand USD | -81894.069% |
T2 Biosystems, Inc. | 6.59 Million USD | -9085.647% |
Neogen Corporation | 888.39 Million USD | 31.779% |
Myriad Genetics, Inc. | 130.9 Million USD | -363.002% |
ICON Public Limited Company | 3.66 Billion USD | 83.465% |
Star Equity Holdings, Inc. | 1.14 Million USD | -52831.79% |
MDxHealth SA | 35.56 Million USD | -1604.164% |
Prenetics Global Limited | 867.21 Thousand USD | -69786.822% |
Illumina, Inc. | 1.48 Billion USD | 59.297% |
DarioHealth Corp. | 24.59 Million USD | -2364.597% |
ENDRA Life Sciences Inc. | 192.06 Thousand USD | -315459.038% |
Medpace Holdings, Inc. | 142.12 Million USD | -326.443% |
Mainz Biomed B.V. | 2.19 Million USD | -27500.166% |
Trinity Biotech plc | 54.65 Million USD | -1008.981% |
Sotera Health Company | 2.22 Billion USD | 72.745% |
bioAffinity Technologies, Inc. | 1.11 Million USD | -54087.424% |